Single-cell repertoire tracing identifies rituximab refractory B cells during myasthenia gravis rela...
Single-cell repertoire tracing identifies rituximab refractory B cells during myasthenia gravis relapses
About this item
Full title
Author / Creator
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Journal title
Language
English
Formats
Publication information
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Subjects
More information
Scope and Contents
Contents
Rituximab, a B cell-depleting therapy, is indicated for treating a growing number of autoantibody-mediated autoimmune disorders. However, relapses can occur after treatment and autoantibody-producing B cell subsets may be found during relapses. It is not understood if these autoantibody-producing B cell subsets emerge from the failed depletion of p...
Alternative Titles
Full title
Single-cell repertoire tracing identifies rituximab refractory B cells during myasthenia gravis relapses
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2314429778
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2314429778
Other Identifiers
E-ISSN
2692-8205
DOI
10.1101/840389
How to access this item
https://www.proquest.com/docview/2314429778?pq-origsite=primo&accountid=13902
